Pharmacogenomics of Alzheimer's disease and cerebral palsy: Implications of the apolipoprotein E genotype

Mark S. Wainwright

doi:10.2217/14796708.2.4.353

Pharmacogenomics of Alzheimer's disease and cerebral palsy: Implications of the apolipoprotein E genotype

Mark S. Wainwright^*

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	353-356
Number of pages	4
Journal	Future Neurology
Volume	2
Issue number	4
DOIs	https://doi.org/10.2217/14796708.2.4.353
State	Published - Jul 2007

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.2217/14796708.2.4.353

Cite this

@article{359dbca13fc342e08dcd95283db10a28,

title = "Pharmacogenomics of Alzheimer's disease and cerebral palsy: Implications of the apolipoprotein E genotype",

author = "Wainwright, {Mark S.}",

year = "2007",

month = jul,

doi = "10.2217/14796708.2.4.353",

language = "English (US)",

volume = "2",

pages = "353--356",

journal = "Future Neurology",

issn = "1479-6708",

publisher = "Taylor and Francis Ltd.",

number = "4",

}

TY - JOUR

T1 - Pharmacogenomics of Alzheimer's disease and cerebral palsy

T2 - Implications of the apolipoprotein E genotype

AU - Wainwright, Mark S.

PY - 2007/7

Y1 - 2007/7

UR - http://www.scopus.com/inward/record.url?scp=34447299381&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447299381&partnerID=8YFLogxK

U2 - 10.2217/14796708.2.4.353

DO - 10.2217/14796708.2.4.353

M3 - Editorial

AN - SCOPUS:34447299381

SN - 1479-6708

VL - 2

SP - 353

EP - 356

JO - Future Neurology

JF - Future Neurology

IS - 4

ER -

Pharmacogenomics of Alzheimer's disease and cerebral palsy: Implications of the apolipoprotein E genotype

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this